Trial intelligence / Profile preview

Placebo-controlled trial on the efficacy of growth hormone replacement therapy after traumatic brain injury

2007-003586-41Phase 4Completed

Sponsor
Pfizer
Start
Aug 2007
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in growth hormone deficiency (GHD) comparing Genotropin with Placebo (2 arms). Primary endpoint: Change from baseline in CogState composite score at Week 36. Started Aug 2007; status: completed.

02

Drugs

somatropin
03

Conditions

growth hormone deficiency (GHD)

Beyond the preview

Go deeper on 2007-003586-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-003586-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call